NPF-Funded Research

Interrogating T-Cell Mediated Mechanisms Underlying the Development of Atherosclerosis in Patients With Psoriasis

Headshot to be 275 x 275 px

Principal Investigator: Patricia Nguyen, M.D.
Institution:
The Board of Trustees of the Leland Stanford Junior University


Grant Mechanism: Discovery Grant
Funding Amount: $75,000
Project Start Date: August 1, 2024
Project End Date: July 31, 2025
Status: Active
Keywords: Comorbidity, CVD, Inflammation

Project Summary:

Coronary artery disease (CAD) happens 150% more often in psoriatic patients. Why CAD occurs more often in psoriatic patients remains unclear. We think that the special immune cells called T cells cause both psoriasis and CAD. We think the same trigger activates T cells in both the skin and vessel. We will analyze the T cells in both the skin and aorta of the mice that have psoriasis and CAD. We will then grow “vessels” from stem cells collected from psoriasis patients. We will add the T cells that are specific to the trigger and see if the T cells activate and damage the “vessel”. If we find this trigger causes disease, then we can make treatment to block the trigger.

How will your project help improve the lives of the 125 million affected by psoriatic disease?

Why is psoriatic disease research important to you, personally? What role will this award play in your research efforts or career development?






Researcher Profile:

Impact of NPF-Funded Research

The NPF has awarded over $30 million in research funding in recent years, with immeasurable impact on our community.

Read more

We Need Your Help

With your gift we can fund even more research to get better treatment and diagnostic options and someday, a cure.

Help fund critical research

NPF-Funded Research

Discover our other active research projects.

Learn more

Stay in the Know

Expert tips, can’t-miss events, and the latest news, straight to your inbox.

National Health Council Standards of ExcellenceCharity NavigatorCommunity Health Charities logo

Copyright © 1996-2024 National Psoriasis Foundation/USA


Duplication, rebroadcast, republication, or other use of content appearing on this website is prohibited without written permission of the National Psoriasis Foundation (NPF).


NPF does not endorse or accept any responsibility for the content of external websites.


NPF does not endorse any specific treatments or medications for psoriasis and psoriatic arthritis.

We use cookies to offer you a better experience and analyze our site traffic. By continuing to use this website, you consent to the use of cookies in accordance with our Privacy Policy.